Sort
53,477 grants matching “addiction”
Center for Biomedical Research Excellence, Epigenomics of Development and Disease
$2,060,766Roxanne A Vaughan · University Of North Dakota · P20 · FY2016 · GM
TMP-301, A Negative Allosteric Modulator of type 5 metabotropic glutamate receptors (mGluR5), for Treatment of Cocaine Use Disorder
$2,060,520Charles Daniel Meyers · Tempero Bio, Inc. · U01 · FY2022 · DA
Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative
$2,059,619Helen S Mayberg · Emory University · U19 · FY2011 · MH
Illuminating neural coding mechanisms using in vivo calcium imaging in freely behaving mice
$2,059,500Da-Ting Lin · National Institute On Drug Abuse · ZIA · FY2020 · DA
Center for Biomedical Research Excellence, Epigenomics of Development and Disease
$2,058,088Roxanne A Vaughan · University Of North Dakota · P20 · FY2017 · GM
Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
$2,058,020Charles Bradberry · National Institute On Drug Abuse · ZIA · FY2017 · DA
Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
$2,057,916Charles Bradberry · National Institute On Drug Abuse · ZIA · FY2018 · DA
ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah
$2,056,330Torri D Metz · University Of Utah · U54 · FY2024 · HD
NIDA Clinical Trials Network: Greater New York Node
$2,054,565John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Frontal Striatal Systems and Dopamine in Normal and Pathological Behavior
$2,054,308Bruno Averbeck · National Institute Of Mental Health · ZIA · FY2019 · MH
Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain
$2,050,367James N Campbell · Centrexion Therapeutics Corporation · UG3 · FY2021 · NS
A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures
$2,050,357Rahul Jadia · Revbio, Inc. · R44 · FY2023 · DE
Indigenous Trauma & Resilience Research Center
$2,048,753Jonathan David Geiger · University Of North Dakota · P20 · FY2022 · GM
Investigation On The Behavioral Effects And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$2,047,482Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2025 · DA
TOBACCO DEPENDENCE AND RISK FACTORS FOR TREATMENT FAILUR
$2,047,370Yale University · P50 · FY2001 · DA
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,047,069Stephen A Spector · University Of California, San Diego · UM1 · FY2021 · AI
Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System
$2,046,880Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$2,046,473Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2023 · DA
Florida Node Alliance of the Drug Abuse Clinic Trials Network
$2,046,113Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2014 · DA
Sleep, opiate withdrawal and the N/OFQ - NOP system
$2,045,252Thomas S Kilduff · Sri International · R01 · FY2019 · HL
Monitoring presynaptic release of neuropeptides in awake behaving animals
$2,045,242Sung Han · Salk Institute For Biological Studies · RF1 · FY2022 · NS
14/24 The Healthy Brain & Child Development National Consortium
$2,045,138Gretchen E. Bandoli · University Of California, San Diego · U01 · FY2024 · DA
Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
$2,043,910Charles Bradberry · National Institute On Drug Abuse · ZIA · FY2019 · DA
TOBACCO DEPENDENCE AND RISK FACTORS FOR TREATMENT FAILUR
$2,043,273Yale University · P50 · FY2002 · DA
Clinical Trials Network, Ohio Valley Node U10DA013732
$2,042,401T John Winhusen · University Of Cincinnati · U10 · FY2014 · DA